ConductScience.org, home

Trial · NCT01873287

Predicting Persistent Postconcussive Problems in Pediatrics (5P)

NCT01873287, Completed, Children's Hospital of Eastern Ontario; results first posted 2019-11-18

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Predicting Persistent Postconcussive Problems in Pediatrics (5P). Trials, record NCT01873287. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01873287

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Predicting Persistent Postconcussive Problems in Pediatrics (5P)
NCT number
NCT01873287
Status
Completed
Enrollment
3,063 participants, actual
Lead sponsor
Children's Hospital of Eastern Ontario
Conditions
Concussions, PCS
First posted
2013-06-10
Last updated
2019-11-18
Results first posted
2019-11-18
Limitations and caveats
Selection bias (children presenting to ED as compared to general primary care) may limit generalizability.~There is no control group (e.g., orthopedic injury) to compare symptom scores. Socio-economic status and race data were not collected.

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryCount of Children Who Have Persistent Post-concussive Symptoms (PCS) at One-month Follow-up.1 month
The primary outcome is the number of of children aged 5 - 17 years who have PCS at one-month follow-up. A PCS case is defined as an increase from pre-concussion baseline of three or more symptoms on the validated PCSI at one-month (consistent with the ICD-10 definition of PCS).
SecondaryPediatric Quality of Life Inventory (PedsQL) Total Score at 4-weeks Post-injury1 month
The PedsQL™ is a reliable and valid measure of health-related quality of life in healthy children and adolescents and those with acute and/or chronic health conditions. Parent versions exist for children aged 2 to 18 years (in 4 age groups) and child versions for those aged 5 and over. The inventory covers four domains: physical, emotional, social and school. Items are calculated and transformed into an overall score with a range of 0 to 100 points, with more points indicating better quality of life. This secondary outcome measure will be used to determine the impact of PCS on quality of life on patients and families.
SecondaryNeuropsychological Evaluation1 month and 3 month
A separate battery of neuropsychological assessment measures will be administered to those children who choose to participate in this arm of the study. This battery includes measures of intelligence, language, visual-spatial/motor functions, attention, memory/working memory, executive functioning, academic achievement, as well as behavioural/socioemotional functioning.

Outcomes3

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYCount of Children Who Have Persistent Post-concussive Symptoms (PCS) at One-month Follow-up.1 monthCompleted 1-month followup.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYPediatric Quality of Life Inventory (PedsQL) Total Score at 4-weeks Post-injury1 monthCompleted PedsQL at 1-month post-concussion.units on a scaleMEAN
SECONDARYNeuropsychological Evaluation1 month and 3 month
Participants assessed at 4- and 12-weeks post-injury using direct, standardized measures of intellectual functioning, verbal memory, executive functioning, attention/working memory, processing speed and fine motor abilities.
ParticipantsCOUNT_OF_PARTICIPANTS

Results by group5

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Count of Children Who Have Persistent Post-concussive Symptoms (PCS) at One-month Follow-up.PPCS in Derivation510Participants
Count of Children Who Have Persistent Post-concussive Symptoms (PCS) at One-month Follow-up.PPCS in Validation291Participants
Pediatric Quality of Life Inventory (PedsQL) Total Score at 4-weeks Post-injuryParticipants With PPCS70.095% Confidence Interval 67.7 to 72.3units on a scale
Pediatric Quality of Life Inventory (PedsQL) Total Score at 4-weeks Post-injuryParticipants Without PPCS80.395% Confidence Interval 78.1 to 82.6units on a scale
Neuropsychological EvaluationNumber of Children With Neuropsychological Impairment32Participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDDerivation Arm2,006
Overall StudySTARTEDValidation Arm1,057
Overall StudyCOMPLETEDDerivation Arm1,701
Overall StudyCOMPLETEDValidation Arm883
Overall StudyNOT COMPLETEDDerivation Arm305
Overall StudyNOT COMPLETEDValidation Arm174

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals3

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityParticipants03,063
Total, other adverse eventsParticipants03,063
Total, serious adverse eventsParticipants03,063

Papers4

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
23906960DERIVEDPubMed
31316452DERIVEDPubMed
32499388DERIVEDPubMed
36854112DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons1

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

Comparison
PPCS in Derivation vs PPCS in Validation: Count of Children Who Have Persistent Post-concussive Symptoms (PCS) at One-month Follow-up.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01873287

GET https://conductscience.org/api/trials/v1/NCT01873287/registered